Cell cycle

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 6, 1998, Pages 310-316

  Gillett, C E ^a   Barnes, D M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DNA;

CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA SYNTHESIS; HUMAN; MITOSIS; PRIORITY JOURNAL; REVIEW; BIOSYNTHESIS; CELL DIVISION; PHYSIOLOGY;

CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA; HUMANS;

EID: 0032409248     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.6.310     Document Type: Review

References (45)

1. Masui Y, Markert CL. Cytoplasmic control of nucleus behavior during meiotic maturation of frog oocytes. J Exp Zool 1971;177:129-46.
2. Smith D, Ecker R. The interaction of steroids with Rana pipiens oocytes in the induction of maturation. Dev Biol 1971;25:232-47.
3. Hartwell LH, Mortimer RK, Culotti J, et al. Genetic control of the cell division cycle in yeast: V. Genetic analysis of CDC mutants. Genetics 1973;74:267-87.
4. Nurse P, Thuriaux P, Nasmyth K. Genetic control of the cell division cycle in fission yeast Schizosaccharomyces pombe. Mol Gen Genet 1976;146:167-78.
5. Evans T, Rosenthal ET, Youngblom J, et al. Cyclin: a protein specified by maternal mRNA in sea urchin eggs is destroyed at each cleavage division. Cell 1983;33:389-96.
6. Chellappan SP, Giordano A, Fisher PB. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. In: Vogt PK, Reed SI, eds. Cyclin dependent kinase (CDK) inhibitors. Berlin: Springer-Verlag, 1998:57-103.
7. Morgan DO. Cyclin-dependent kinases: engines, clocks and microprocessors. Ann Rev Cell Dev Biol 1997;13:261-91.
8. CDK2 protein kinase subunits. Mol Biol Cell 1992;3:1279-94.
9. Lees EM, Harlow E. Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and inactivation of CDC2 kinase. Mol Cell Biol 1993;13:1194-201.
10. Murray A. Cyclin uhiquitination: the destructive end of mitosis. Cell 1995;81:149-52.
11. King RW, Deshais RJ, Peters J-M, et al. How proteolysis drives the cell cycle. Science 1996;274:1652-9.
12. Solomon MJ, Lee T, Kirschner MW. Role of phosphorylation in p34CDC2 activation: identification of an activating kinase. Mol Biol Cell 1992;3:13-27.
13. Fisher RP, Morgan DO. A novel cyclin associates with MO15/CDK7 to form the CDK-activatmg kinase. Cell 1994;78:713-24.
14. Bates S, Parry D, Bonetta L, et al. Absence of cyclin D CDK complexes in cells lacking functional retinoblastoma protein. Oncogene 1994;9:1633-40.
15. Sherr CJ. D-type cyclins. Trends Bioehem Sci 1995;20:187-90.
16. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
17. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
18. Stillman B. Cell cycle control of DNA replication. Science 1996;274:1659-64.
19. Ford C, Chevalier S . DNA replication. Almost licensed. Curr Biol 1995;5:1009-12.
20. Minnick DT, Kunkel TA. DNA synthesis errors, mutators and cancer. Cancer Surv 1996;28:3-20.
21. Hickey RJ, Malkas LH. Mammalian cell DNA replication. Crit Rev Eukaryot Gene Expr 1997;7:125-5.
22. Jackman M, Firth M, Pines J. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J 1995; 14:1646-54.
23. McGowan CH, Russell P. Cell cycle regulation of human WEE1. EMBO J 1995;14:2166-75.
24. Morgan DO. Principles of CDK regulation. Nature 1995;374:131-4.
25. McIntosh JR, Koonce MP. Mitosis. Science 1989;246:622-8.
26. Cooper GM. The cell: a molecular approach. Washington DC: ASM Press, 1997.
27. Pomerantz J, Schreiber-Agus N, Liégeois J, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-23.
28. Weinberg RA. The molecular basis of carcinogenesis: understanding the cell cycle clock. Cytokines and Molecular Therapy 1996;2:105-10.
29. Hengst L, Reed SI. Translational control of p27Kip1 accumulation during the cell cycle. Science 1996;271:1861-4.
30. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8.
31. Soos TJ, Kiyokawa H, Yan JS, et al. Formation of p27. CDK complexes during the human mitotic cell cycle. Cell Growth Differ 1996;7:135-46.
32. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993:366:704-7.
33. LaBaer J, Garrett MD, Stevenson LF, et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997;11:847-62.
34. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
35. Matsuoka S, Edwards MC, Bai C, et al. p57KIP2, a structurally distinct member of the p21CIP1 CDK inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995;9:650-62.
36. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3.
37. Orr-Weaver, Weinberg RA. A checkpoint on the road to cancer. Nature 1998;392:223-4.
38. Linden MD, Torres FX, Kubus J, et al. Clinical application of morphologic and immunochemical assessments of cell proliferation. Am J Clin Pathol 1992;97:S4-13.
39. Baak JPA. Mitosis counting in tumors. Hum Pathol 1990;21: 683-5.
40. Meyer JS, Bauer WC. In vitro determination of tritiated thymidine labeling index. Cancer 1975;36:1374-80.
41. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
42. Schwarting R. Little missed markers and Ki-67. Lab Invest 1993;68:597-9.
43. Fantl V, Stamp G, Andrews A, et al. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 1995;9:2364-72.
44. Kap1. Cell 1996;85:721-32.
45. CEP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995;82: 675-84.